Consolidated Statements Of Earnings (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Net sales	$ 8,307	$ 7,320	$ 6,723
Cost of sales	2,811	2,286	2,184
Gross profit	5,496	5,034	4,539
Research, development and engineering expenses	462	394	336
Selling, general and administrative expenses	3,150	2,707	2,506
Intangibles asset amortization	122	58	36
Property, plant and equipment impairment		124
Restructuring charges	76		67
Total operating expenses	3,810	3,283	2,945
Operating income	1,686	1,751	1,594
Other income (expense)		(22)	30
Earnings before income taxes	1,686	1,729	1,624
Income taxes	341	456	517
Net earnings	$ 1,345	$ 1,273	$ 1,107
Net earnings per share of common stock:
Basic net earnings per share of common stock	$ 3.48	$ 3.21	$ 2.79
Diluted net earnings per share of common stock	$ 3.45	$ 3.19	$ 2.77
Weighted-average shares outstanding-in millions:
Basic	386.5	396.4	397.4
Employee stock options	10.8	10.6	20.1
Less antidilutive stock options	(7.8)	(7.5)	(18.1)
Net effect of dilutive employee stock options	3.0	3.1	2.0
Diluted	389.5	399.5	399.4